Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467753 · ClinicalTrials.gov registry record · NA
Oxcarbazepine Versus Placebo in Childhood Autism
A NA study of Autism, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT00467753: Completed NA study of Autism, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00467753 is a NA study of Autism that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 5 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467753, a NA study of Autism, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty subjects between the ages of five and seventeen with a diagnosis of autism.
Primary Outcome
The Vineland Scale is a semi-structured informant interview that assesses subjects' functioning. It is administered to a caretaker/family member. The scale has been revised and standardized in all populations. This scale has been found to assess social deficits in autism and strengths in daily living skills. Items are classified under four major adaptive domains: communication, daily living skills, socialization and motor skills. The items are scored 0-2 (yes/sometimes/never). Each domain is sum
Conditions Studied
Interventions
- DRUG Oxcarbazepine
- OTHER Placebo/sugar pill
Study Locations (1)
New Jersey
- Child and Adolescent Psychiatry at the University Behavioral Healthcare Building, UMDNJ-RWJMS - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT00467753 record still lists
NCT00467753 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Oxcarbazepine is the first listed.
NCT00467753 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00467753 about?
NCT00467753 is a clinical study titled "Oxcarbazepine Versus Placebo in Childhood Autism". The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty subjects between the ages of five and seventeen with a diagnosis of autism.
What is the current status of trial NCT00467753?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2006-04. Estimated completion is 2011-12.
What conditions does trial NCT00467753 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT00467753?
The interventions under investigation include: Oxcarbazepine (DRUG), Placebo/sugar pill (OTHER).
Who is sponsoring clinical trial NCT00467753?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00467753 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00467753's enrollment target sits among peer trials
5 104th of 104 the lowest of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia